[Effect of serotonin and histamine antagonists (deseryl and tawegil) on uropepsin and 5-hydroxyindoleacetic acid excretion in patients with stomach and duodenal ulcer and in healthy subjects].
D004381:Duodenal Ulcer / Q000503:physiopathology*; D010450:Endopeptidases / Q000652:urine*; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine*; D008784:Methysergide / Q000494:pharmacology*; D012702:Serotonin Antagonists; D013276:Stomach Ulcer / Q000503:physiopathology*
D006634:Histamine H1 Antagonists; D012702:Serotonin Antagonists; D006897:Hydroxyindoleacetic Acid; D010450:Endopeptidases; D008784:Methysergide
Wpływ antagonisty serotoniny (deseryl) i histaminy (tawegil) na wydalanie uropepsyny i kwasu 5-hydoksyindolooctowego u chorych na chorobe wrzodowa zoładka i dwunastnicy oraz u osób zdrowych.